10x Genomics (TXG) Competitors $12.08 +0.51 (+4.36%) As of 09:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TXG vs. MIR, ST, CAMT, TRNS, ALNT, EYPT, LAB, CTKB, AEHR, and SENSShould you be buying 10x Genomics stock or one of its competitors? The main competitors of 10x Genomics include Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), Transcat (TRNS), Allient (ALNT), Eyepoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), and Senseonics (SENS). These companies are all part of the "measuring and control equipment" industry. 10x Genomics vs. Its Competitors Mirion Technologies Sensata Technologies Camtek Transcat Allient Eyepoint Pharmaceuticals Standard BioTools Cytek Biosciences Aehr Test Systems Senseonics 10x Genomics (NASDAQ:TXG) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability. Which has stronger earnings & valuation, TXG or MIR? Mirion Technologies has higher revenue and earnings than 10x Genomics. Mirion Technologies is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.44-$182.63M-$1.30-9.30Mirion Technologies$860.80M5.48-$36.10M-$0.06-338.90 Is TXG or MIR more profitable? Mirion Technologies has a net margin of -1.16% compared to 10x Genomics' net margin of -25.14%. Mirion Technologies' return on equity of 6.07% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-25.14% -23.22% -18.02% Mirion Technologies -1.16%6.07%3.60% Do analysts rate TXG or MIR? 10x Genomics currently has a consensus target price of $14.96, indicating a potential upside of 23.80%. Mirion Technologies has a consensus target price of $18.75, indicating a potential downside of 7.79%. Given 10x Genomics' higher probable upside, equities research analysts plainly believe 10x Genomics is more favorable than Mirion Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.43Mirion Technologies 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Do insiders & institutionals believe in TXG or MIR? 84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 10.0% of 10x Genomics shares are held by company insiders. Comparatively, 2.2% of Mirion Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, TXG or MIR? 10x Genomics has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Does the media favor TXG or MIR? In the previous week, 10x Genomics had 8 more articles in the media than Mirion Technologies. MarketBeat recorded 14 mentions for 10x Genomics and 6 mentions for Mirion Technologies. 10x Genomics' average media sentiment score of 0.79 beat Mirion Technologies' score of 0.58 indicating that 10x Genomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mirion Technologies 2 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMirion Technologies beats 10x Genomics on 9 of the 17 factors compared between the two stocks. Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXG vs. The Competition Export to ExcelMetric10x GenomicsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.47B$2.08B$5.48B$8.94BDividend YieldN/AN/A5.38%4.12%P/E Ratio-9.2036.1026.2219.74Price / Sales2.4415.83394.92109.12Price / CashN/A56.8136.4957.06Price / Book2.088.637.915.37Net Income-$182.63M-$63.71M$3.15B$248.34M7 Day Performance3.64%0.87%0.75%1.67%1 Month Performance27.88%2.59%3.46%4.56%1 Year Performance-35.96%2.53%34.60%18.42% 10x Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXG10x Genomics4.5673 of 5 stars$12.09+4.4%$14.96+23.8%-35.1%$1.47B$610.78M-9.201,240MIRMirion Technologies0.8109 of 5 stars$20.33+3.5%$18.75-7.8%+93.2%$4.72B$860.80M-338.832,860High Trading VolumeSTSensata Technologies4.6403 of 5 stars$28.63+1.3%$34.08+19.0%-16.7%$4.19B$3.93B35.3519,000News CoverageAnalyst ForecastCAMTCamtek2.9819 of 5 stars$74.85+1.2%$90.78+21.3%-35.8%$3.41B$429.23M28.68400Analyst ForecastTRNSTranscat2.9444 of 5 stars$80.27-0.3%$114.00+42.0%-26.9%$748.12M$278.42M51.461,245ALNTAllient2.2627 of 5 stars$34.61+2.6%$31.00-10.4%+50.5%$585.95M$529.97M58.662,525EYPTEyepoint Pharmaceuticals2.3946 of 5 stars$8.28-1.7%$25.67+210.0%+14.9%$569.75M$43.27M-3.44120LABStandard BioTools3.24 of 5 stars$1.23+17.1%$2.50+103.3%-25.4%$467.18M$174.43M-3.51620Gap UpHigh Trading VolumeCTKBCytek Biosciences3.1596 of 5 stars$3.12+5.8%$5.60+79.5%-38.0%$395.18M$200.45M-34.66500High Trading VolumeAEHRAehr Test Systems4.0426 of 5 stars$11.25+0.9%$25.00+122.2%+27.1%$334.91M$66.22M14.4290News CoverageGap DownSENSSenseonics1.8885 of 5 stars$0.50-2.9%$1.55+212.3%+20.2%$324.69M$23.68M-3.8290 Related Companies and Tools Related Companies Mirion Technologies Alternatives Sensata Technologies Alternatives Camtek Alternatives Transcat Alternatives Allient Alternatives Eyepoint Pharmaceuticals Alternatives Standard BioTools Alternatives Cytek Biosciences Alternatives Aehr Test Systems Alternatives Senseonics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TXG) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts